The FDA is soliciting comments from industry members and shareholders on how direct-to-consumer drug advertising should depict risk information. Source: Drug Industry Daily

A company that warehouses drugs but doesn’t own them fits into a new category to be regulated under a 2013 federal law that aims to tighten security over the drug…

A bill reauthorizing the FDA’s user fee agreements for the next five years become law Aug.18 when President Trump signed it. Source: Drug Industry Daily

Doctors may contact the FDA by phone, fax or email to seek approval for emergency use of an investigative drug, but a phone call is best after hours, the agency…

Biocon said it plans to re-submit applications for European approval of two cancer-treatment biosimilars as soon as it corrects serious GMP deficiencies found at a Bangalore manufacturing plant. The company…

Two Democratic members of the House Oversight Committee sent a letter to seven drugmakers over price increases of multiple sclerosis drugs. Source: Drug Industry Daily

South Carolina has joined the long list of states taking legal action against Purdue Pharma, maker of OxyContin (oxycodone), the company’s extended-release prescription opioid painkiller. Source: Drug Industry Daily

An Ohio advocacy group filed a complaint with the state’s Election Commission claiming drugmakers covertly funded efforts against a drug pricing ballot initiative. Source: Drug Industry Daily

The FDA’s proposal to analyze the effect of prescription drug advertising is unnecessary and vague, according to PhRMA. Source: Drug Industry Daily

The state of Maryland defended its law against generic drug price gouging in court, moving to dismiss a complaint brought by the industry’s trade group, the Association for Accessible Medicines.…